Home › Brands › Canopy Growth
⚐ Flag an error How this page was made
Also known as: Canopy Growth Corporation · CGC · Tweed (original brand)

Canopy Growth

Canadian cannabis producer and public company with portfolio brands and U.S. options.

Automated fact-check pass
11 cited sources
Published
Last reviewed
How this page was made
↯ The honest take

Canopy Growth is Canada's largest listed cannabis company by historical market cap, but it has lost billions annually and restructured repeatedly since 2020. Its biggest shareholder, Constellation Brands, has written down its stake multiple times. The company operates real, licensed operations in Canada but its U.S. holdings sit in a legal holding structure that converts only if federal prohibition ends. Track their filings, not press releases.

What it is

Canopy Growth Corporation is a Canadian cannabis company headquartered in Smiths Falls, Ontario, on the site of a former Hershey chocolate factory acquired in 2014 [1]. It was originally incorporated as Tweed Marijuana Inc. and became one of the first cannabis companies listed on a major stock exchange when it joined the Toronto Stock Exchange in 2016, later cross-listing on the Nasdaq in 2018 [2]. The company holds Canadian federal licenses to cultivate, process, and sell cannabis under Health Canada's Cannabis Act framework [3]. Its business spans Canadian adult-use and medical cannabis, international medical exports in selected markets, and a separate U.S.-focused holding structure.

Ownership and corporate structure

Canopy Growth is a publicly traded company on the Nasdaq (CGC) and Toronto Stock Exchange (WEED); it has no single parent corporation [2]. The most significant historical shareholder has been Constellation Brands (the U.S. alcohol company behind Corona and Modelo), which invested roughly CA$5 billion in 2017–2018 to take a large minority stake [4]. Constellation has since written down much of that investment and reduced its position substantially [5]. In 2024, Canopy shareholders approved a restructuring that ended Constellation's special governance rights [6].

To navigate U.S. federal cannabis prohibition while maintaining its Nasdaq listing, Canopy created Canopy USA, LLC as a separate holding vehicle. Canopy USA holds options or conditional interests in U.S. cannabis assets — including edibles maker Wana Brands, California concentrate brand Jetty Extracts, and multi-state operator Acreage Holdings — that would only fully consolidate if and when U.S. federal law permits [7]. Whether and when those options convert into ownership has been renegotiated repeatedly; readers should check the latest SEC and SEDAR+ filings rather than older announcements.

Brands and product portfolio

Canopy operates a portfolio of consumer brands rather than a single label. The most visible in Canada include:

The company has closed several facilities and shut down earlier brands as part of cost-cutting. Its original Smiths Falls production operations were closed in 2023. Outside Canada, Canopy operates Storz & Bickel, the German manufacturer of the Volcano and Mighty vaporizers, which it acquired in 2018 [8]. Through Canopy USA's options, U.S. consumers may encounter Wana gummies and Jetty vapes in state-legal markets, though those companies operate independently under the current structure [7]. This profile does not recommend specific products.

Financial performance and corporate controversies

Canopy has been one of the most-covered cannabis companies in business media, largely because of its size, the Constellation investment, and its subsequent losses. Reporting from Reuters, the Globe and Mail, and MJBizDaily has documented multi-billion-dollar annual losses, repeated restructurings, facility closures, and large asset impairments through 2022–2024 [5][9]. The company has missed several profitability targets previously communicated to investors [5][9].

Notable events include closure of the Smiths Falls production facility and significant layoffs across 2020–2023, and ongoing debate among analysts about whether the Canopy USA structure complies with Nasdaq listing requirements [6]. The company has received industry awards over the years, but cannabis-industry awards are generally sponsor-driven and should not be read as independent quality verification No data.

Canopy's adult-use products are sold through provincial wholesalers and licensed retailers across Canada under the federal Cannabis Act [3]. Medical cannabis is sold directly to registered patients in Canada and exported to a limited set of international medical markets subject to import permits in each jurisdiction. Storz & Bickel vaporizers are sold globally as medical or consumer devices depending on the country.

In the United States, Canopy Growth itself does not sell THC products directly; that activity sits inside Canopy USA's option holdings, which only convert under specific legal conditions [7]. CBD products under Canopy-affiliated brands have been sold in some U.S. states, but availability has changed over time. Availability of specific SKUs varies by province and retailer; provincial retail listings and Health Canada's licensed-producer database are the primary sources of truth.

What to verify before relying on brand claims

Because Canopy has restructured frequently and closed major facilities, treat older press releases and investor decks with caution. Before relying on any specific claim about the company, verify against primary sources:

Do not assume continuity: brands, SKUs, facilities, and ownership of U.S.-facing assets have all changed materially within recent years. Last verified October 2026.

Sources

  1. Reported Austen, I. (2016). 'A Canadian Chocolate Factory's Second Life Growing Marijuana.' The New York Times.
  2. Reported Reuters Staff (2018). 'Canopy Growth becomes first cannabis firm to list on NYSE.' Reuters.
  3. Government Health Canada. 'Licensed cultivators, processors and sellers of cannabis under the Cannabis Act.'
  4. Reported Reuters (2018). 'Constellation Brands to invest $4 billion more in cannabis producer Canopy Growth.' Reuters.
  5. Reported Israel, S. (2023). 'Constellation Brands writes down Canopy Growth stake again as cannabis bet sours.' MJBizDaily.
  6. Reported Schmidt, E. (2024). 'Canopy Growth shareholders approve restructuring tied to Canopy USA and U.S. cannabis assets.' MJBizDaily.
  7. Reported Schmidt, E. (2022). 'Canopy Growth creates U.S.-focused holding company to consolidate Acreage, Wana, Jetty.' MJBizDaily.
  8. Reported Reuters (2018). 'Canopy Growth to acquire German vaporizer maker Storz & Bickel for about $220 million.' Reuters.
  9. Reported MJBizDaily Staff. 'Canopy Growth financial results coverage.' MJBizDaily.
  10. Government Canadian Securities Administrators. 'SEDAR+ public filings database — Canopy Growth Corporation.'
  11. Government U.S. Securities and Exchange Commission. 'EDGAR filings — Canopy Growth Corporation.'

How this page was made

Generation history

Oct 31, 2026
Fact-check pass — raised 6 flags
Oct 31, 2026
Revision
Jun 8, 2026
Fact-check pass — raised 2 flags
Jun 8, 2026
Initial draft

Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.